Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yu. Yu. Varlamova"'
Autor:
A. I. Sapina, Yu. Yu. Varlamova, M. G. Papyrina, A. S. Bezymyanny, E. L. Kordzaya, E. Yu. Vasilyeva
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 6 (2024)
Aim. To evaluate the effectiveness of PCSK9-targeted therapy (inclisiran, alirocumab, and evolocumab) in patients with atherosclerotic cardiovascular disease (ASCVD) and who did not achieve the target low-density lipoprotein cholesterol (LDL-C) level
Externí odkaz:
https://doaj.org/article/83920f54285d431894c86ace5d869e34
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 12 (2023)
Aim. To evaluate the effectiveness of PCSK9 inhibitors (alirocumab, inclisiran and evolocumab) in patients with atherosclerotic cardiovascular disease (ASCVD) and failure to achieve the target low-density lipoprotein cholesterol (LDL-C) level for the
Externí odkaz:
https://doaj.org/article/db88a5b976c64fde8b9173d30faba94f
Autor:
V. N. Larina, T. N. Mironova, V. G. Larin, U. V. Makhova, D. A. Orlov, Yu. Yu. Varlamova, O. V. Kladovikova
Publikováno v:
Kardiologiia. 63:11-15
Aim To evaluate the frequency and structure of lipid-lowering therapy and of achieving the goal of low-density lipoprotein cholesterol (LDL-C) in patients with very high cardiovascular risk (CVR) who were monitored at the outpatient stage. Material a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::052260cb72ab9ee14490cc33c45abe6b
https://doi.org/10.18087/cardio.2023.4.n2396
https://doi.org/10.18087/cardio.2023.4.n2396